1. 1263. Assessment of Cefepime (FEP)-Taniborbactam (TAN) Human Exposures to Suppress the Emergence of Resistance among Serine (SBL)- and Metallo-β-Lactamase (MBL)-Producing Gram-Negative Bacteria (GNB) in a Hollow Fiber Infection Model (HFIM). (31st December 2020) Authors: Avery, Lindsay M; Vernacchio, Salvador; McLaughlin, Lisa; Xerri, Luigi; Moeck, Greg; Pevear, Daniel Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S648 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1370. Cefepime/VNRX-5133 Broad-Spectrum Activity Is Maintained Against Emerging KPC- and PDC-Variants in Multidrug-Resistant K. pneumoniae and P. aeruginosa. (26th November 2018) Authors: Daigle, Denis; Hamrick, Jodie; Chatwin, Cassandra; Kurepina, Natalia; Kreiswirth, Barry N; Shields, Ryan K; Oliver, Antonio; Clancy, Cornelius J; Nguyen, Minh-Hong; Pevear, Daniel; Xerri, Luigi Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S419 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1395. Defining the Magnitude of AUC:MIC Driver for Efficacy of the β-Lactamase Inhibitor VNRX-5133 When Combined with Cefepime Against KPC- and VIM/NDM-Producing Enterobacteriaceae and P. aeruginosa. (26th November 2018) Authors: Daigle, Denis; Vernacchio, Salvador; Xerri, Luigi; Pevear, Daniel Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S429 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗